Tag Archives: Aclidinium monotherapyunder

Spanish pharmaceutical company Almirall released its H1 2013 financial results

Barcelona,  05-8-2013 — /EuropaWire/ — Almirall’s H1: Executing on growth platforms, financial delivery on track Financial performance in line with guidance Aclidinium now available in 13 countries with five new launches planned before year’s end US/EU filings of aclidinium/formoterol combination are … Read the full press release